Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 10 studies | 25% ± 12% | |
microglial cell | 9 studies | 30% ± 11% | |
glutamatergic neuron | 7 studies | 42% ± 22% | |
macrophage | 7 studies | 28% ± 7% | |
oligodendrocyte precursor cell | 7 studies | 27% ± 12% | |
GABAergic neuron | 7 studies | 36% ± 19% | |
oligodendrocyte | 7 studies | 24% ± 8% | |
interneuron | 6 studies | 37% ± 20% | |
epithelial cell | 6 studies | 29% ± 8% | |
astrocyte | 6 studies | 30% ± 10% | |
neuron | 4 studies | 27% ± 9% | |
basal cell | 4 studies | 25% ± 14% | |
granule cell | 3 studies | 22% ± 4% | |
progenitor cell | 3 studies | 29% ± 6% | |
fibroblast | 3 studies | 22% ± 5% | |
transit amplifying cell | 3 studies | 34% ± 22% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 11 studies | 31% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2060.03 | 1445 / 1445 | 100% | 32.75 | 183 / 183 |
ovary | 100% | 3586.59 | 180 / 180 | 100% | 13.12 | 429 / 430 |
brain | 100% | 1459.72 | 2634 / 2642 | 100% | 20.04 | 705 / 705 |
breast | 100% | 2367.15 | 459 / 459 | 100% | 23.34 | 1113 / 1118 |
lung | 100% | 1857.96 | 576 / 578 | 100% | 16.84 | 1152 / 1155 |
uterus | 100% | 2721.32 | 170 / 170 | 99% | 17.82 | 456 / 459 |
thymus | 100% | 2356.38 | 653 / 653 | 99% | 13.16 | 598 / 605 |
bladder | 100% | 2114.62 | 21 / 21 | 98% | 12.90 | 492 / 504 |
pancreas | 100% | 1731.46 | 327 / 328 | 98% | 11.16 | 174 / 178 |
stomach | 100% | 1509.27 | 359 / 359 | 95% | 14.60 | 273 / 286 |
intestine | 100% | 1810.98 | 966 / 966 | 95% | 11.21 | 499 / 527 |
skin | 100% | 3683.12 | 1809 / 1809 | 94% | 16.87 | 445 / 472 |
kidney | 100% | 1289.67 | 89 / 89 | 94% | 11.60 | 845 / 901 |
prostate | 100% | 1709.88 | 245 / 245 | 75% | 5.50 | 376 / 502 |
adrenal gland | 100% | 1520.22 | 258 / 258 | 74% | 4.94 | 171 / 230 |
liver | 99% | 823.66 | 224 / 226 | 70% | 5.11 | 284 / 406 |
spleen | 100% | 1468.93 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.97 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.42 | 1 / 1 |
adipose | 100% | 2207.22 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1619.98 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1172.54 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 1154.90 | 826 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 7.08 | 27 / 29 |
eye | 0% | 0 | 0 / 0 | 76% | 5.65 | 61 / 80 |
peripheral blood | 30% | 796.22 | 275 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005694 | Cellular component | chromosome |
Gene name | QSER1 |
Protein name | Glutamine and serine-rich protein 1 Glutamine and serine rich 1 |
Synonyms | |
Description | FUNCTION: Plays an essential role in the protection and maintenance of transcriptional and developmental programs. Protects many bivalent promoters and poised enhancers from hypermethylation, showing a marked preference for these regulatory elements over other types of promoters or enhancers. Mechanistically, cooperates with TET1 and binds to DNA in a common complex to inhibit the binding of DNMT3A/3B and therefore de novo methylation. . |
Accessions | A0A3B3IRW6 ENST00000524678.1 A0A3B3ISY4 H0YCQ7 Q2KHR3 ENST00000650167.2 ENST00000527250.5 |